Isolated trisomy 15 : A clonal chromosome abnormality in bone marrow with doubtful hematologic significance

American Journal of Clinical Pathology

Volumn 129, Issue 3, 2008, Pages 478-485

  Hanson, Curtis A ^a,b   Steensma, David P ^a   Hodnefield, Janice M ^a   Nguyen, Phuong L ^a   Hoyer, James D ^a   Vtswanatha, David S ^a   Zou, Ying ^a   Knudson, Ryan A ^a   Van Dyke, Daniel L ^a   Ketterling, Rhett P ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bone marrow; Cytogenetics; Myelodysplastic syndromes; Trisomy 15

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; MALE; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; TRISOMY 15; Y CHROMOSOME; BONE MARROW CELL; CHROMOSOME 15; CHROMOSOME DELETION; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; MIDDLE AGED; PHYSIOLOGY; TRISOMY;

AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, Y; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; TRISOMY;

EID: 41649109257     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/2VQLDHVJB9YW83KB     Document Type: Article

References (31)

1. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999;340:1649-1660.
2. Bennett JM. A comparative review of classification systems in myelodysplastic syndromes (MDS). Semin Oncol. 2005;32(4 suppl 5):S3-S10.
3. Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc. 2006;81:104-130.
4. Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res. 2003;27:95-120.
5. List A, Kurtin S, Roe DJ, et al. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med. 2005;352:549-557.
6. Sole F, Espinet B, Sanz GF, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes.Br J Haematol. 2000;108:346-356.
7. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
8. Steensma DP, List AF. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc. 2005;80:681-698.
9. Cherian S, Bagg A. The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights. Hematology. 2006;11:1-13.
10. Morice WG, Kurtin PJ, Tefferi A, et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood. 2002;99:268-274.
11. Spurbeck JL, Carlson RO, Allen JE, et al. Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genet Cytogenet. 1988;32:59-66.
12. Wiktor AE, Van Dyke DL, Stupca PJ, et al. Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genetics Med. 2006;8:16-23.
13. Dewald G, Brockman S, Paternoster S, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of chronic lymphocytic leukemia. Br J Haematol. 2003;121:287-295.
14. McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol. 2005;29:1652-1660.
15. Mitelman F, ed. ISCN 1995: An International System for Human Cytogenetic Nomenclature 1995. Basel, Switzerland: S Karger; 1995.
16. Steensma DP, Dewald GW, Hodnefield JM, et al. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? Leuk Res. 2003;27:235-242.
17. Sinclair EJ, Potter AM, Watmore AE, et al. Trisomy 15 associated with loss of the Y chromosome in bone marrow: a possible new aging effect. Cancer Genet Cytogenet. 1998;105:20-23.
18. Natelson EA. Myelodysplasia with isolated trisomy 15: a 15-year follow-up without specific therapy. Am J Med Sci. 2006;331:157-158.
19. Morel F, Le Bris MJ, Herry A, et al. Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature. Leuk Lymphoma. 2003;44:549-551.
20. Vadlamani I, Ma E, Brink DS, et al. Trisomy 15 in a case of pediatric hemangiopericytoma and review of the literature. Cancer Genet Cytogenet. 2002;138:116-119.
21. Sashida G, Tauchi T, Kimura Y, et al. Trisomy 15 as a single autosomal abnormality in a patient with unclassifiable myelodysplastic syndromes [letter]. Cancer Genet Cytogenet. 2001;127:91-92.
22. Suzuki A, Ohyashiki K, Kimura Y, et al. Frequent association between trisomy 15 and t(8;21)(q22;q22) in acute myeloid leukemia [letter]. Cancer Genet Cytogenet. 2001;126:169-170.
23. Batanian JR, Slovak ML, Mohamed A, et al. Trisomy 15 is frequently observed as a minor clone in patients with anemia/ MDS/NHL and as a major clone in patients with AML. Cancer Genet Cytogenet. 2000;121:186-189.
24. Baumgartner BJ, Shurafa M, Terebelo H, et al. Trisomy 15, sex chromosome loss, and hematological malignancy. Cancer Genet Cytogenet. 2000;117:132-135.
25. Reddy KS, Sbeiti A. Trisomy 15 in hematological disorders [letter]. Cancer Genet Cytogenet. 2000;116:176-177.
26. Smith A, Watson N, Sharma P. Frequency of trisomy 15 and loss of the Y chromosome in adult leukemia. Cancer Genet Cytogenet. 1999;114:108-111.
27. Oliver JW, Deol I, Morgan DL, et al. Chronic eosinophilic leukemia and hypereosinophilic syndromes: proposal for classification, literature review, and report of a case with a unique chromosomal abnormality. Cancer Genet Cytogenet. 1998;107:111-117.
28. Weide R, Rieder H, Mehraein Y, et al. Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. Br J Haematol. 1997;96:117-123.
29. Smith SR, Rowe D. Trisomy 15 in hematological malignancies: six cases and review of the literature. Cancer Genet Cytogenet. 1996;89:27-30.
30. Wong KF, Chan JK, Kwong YL, et al. B-cell small lymphocytic lymphoma with circulating granular prolymphocytes and a novel trisomy 15 anomaly. Cancer Genet Cytogenet. 1995;81:28-32.
31. Wiktor A, Rybicki BA, Piao ZS, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer. 2000;27:11-16.